Upon lactification, Insulin-like Growth Factor 2 mRNA-Binding Protein 3 (IGF2BP3) stabilizes both PCK2 and NRF2 mRNA, augments the activity of the antioxidant system, and bolsters the resistance of hepatocellular carcinoma (HCC) to lenvatinib. Here, PCK2 is linked to hepatocellular carcinoma.